4th World Congress on Epilepsy and Nervous system Disorders
Epilepsy Treatment 2018 conference brings together Speakers and attendees and decision-makers from different biotechnology and medical companies, major pharmaceutical and device companies, and researchers and innovators at the cutting-edge of epilepsy and CNS treatment advances.
- (1888PressRelease) May 01, 2018 - Epilepsy is a non-communicable disorder of the brain that affects people of all ages. According to WHO (World Health Organization) statistics more than 50 million people are affected in the world. It is estimated that every year nearly 2.4 million people are diagnosed with epilepsy and the population with active epilepsy is between 4 to10 per 1000 people. Approximately 50 million people in the world have epilepsy, now days which is one of the common neurological diseases globally. Nearly 80% people in the world live in low- and middle-income countries with epilepsy. Approximately 70% of the people with epilepsy living in low-and middle-income countries get treatment as they need & rest of 3/4th people, they do not get. In different parts of the world, many families with epilepsy suffer from stigma and discrimination.
WHY TO ATTEND THE CONFERENCE
Epilepsy Treatment 2018 conference brings together Speakers and attendees and decision-makers from different biotechnology and medical companies, major pharmaceutical and device companies, and researchers and innovators at the cutting-edge of epilepsy and CNS treatment advances. Also to create an agenda with highly innovative topics on epilepsy treatment, therapeutic innovation, and product development. Initiate demos, share information, come across with eminent personalities, and create novel antiepileptic line and latest diagnostic methods at this outstanding event.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam